Browse
Shopping Cart
clear

Request a Demo or a Quote

Your contact information:
Product Information:
About Us

Reimagining Cell Analysis to Fuel Scientific Discovery

Cytek Biosciences is committed to providing powerful solutions that enable scientists to rapidly, efficiently obtain deep biological insights through high quality, high parametric datasets.

We are on a mission to advance cancer and cell biology research using a powerful cell analysis technique called flow cytometry.

We are satisfying long unmet needs in fields of research such as cancer biology, immunology and genomics – and helping to advance our collective understanding and diagnosis of cancer. Our products are used at many of the world’s most renown pharmaceutical and CRO firms and cancer research institutions.

As a company, we seek to maintain high ethical standards and a culture that values honesty, integrity and transparency in all that we do. Company decisions are driven by what is right for scientific discovery and customer support. We are committed to our employees, to the environment in which we live and to the communities we serve worldwide.

Our Achievements

The Aurora

In 2017, we launched our flagship product, the Aurora. Leveraging powerful fiber optic technology and spectral analysis, the Aurora has revolutionized the flow cytometry industry. It is considered the premier flow cytometer, and leads the way in the field of high-parametric cytometry.

Read More

40 Color Flow Cytometry

Always ready for new challenges, we continually update and push the boundaries of our flow cytometry solutions. In 2019, using a five-laser Aurora, a team of Cytek scientists developed, optimized, and successfully ran a 40-color application panel in one sample tube. This achievement gives scientists the ability to obtain deeper insights from a limited sample at a fraction of the time and cost, compared to other systems. The Aurora is the world’s first commercialized fluorescence-based flow cytometer to produce high quality 40-color data.

Read More

Global Adoption

Cytek products have been well received in more than 20 countries across five continents. Our solutions are rapidly gaining traction with scientists and clinicians around the globe: more than 200 of Cytek’s advanced flow cytometry systems have been installed in the field.

Read More

Our Certifications and Licenses

ISO 9001 certification
Medical Device Manufacturing License

Medical Device Manufacturing License

Leadership Team

Our team has a unique balance of Financial, Technical, and Operational Management experience focused on agile product development and efficient operations. Our Leaders emphasize delivering Customer Value through Technical Innovation and Superior Customer Service

Wenbin Jiang Ph.D.
Chief Executive Officer
Ming Yan Ph.D.
Chief Technology Officer
Ken Riley, PMP
General Manager
Patrik Jeanmonod
Chief Financial Officer
Steve Ziganti
VP of Worldwide Sales
Ray Lannigan
VP of U.S. Sales
Gil Reinin
Director of Marketing, Research
Mark Herberger
Director of Marketing, Clinical

Join Our Team

Cytek® is a growing company that is always looking for energetic, educated professionals. Expand your possibilities professionally and personally, and join us.

View Job Listings

Board of Directors

Wenbin Jiang Ph.D.
Cytek Biosciences, C.E.O.

Dr. Jiang is a co-founder of Cytek Biosciences, Inc. and a seasoned entrepreneur and inventor. E2O communications was the first company he cofounded in late 1990s, which was acquired by JDS Uniphase in 2004. He is an inventor of more than 90 US patents and an author of 4 book chapters and more than 50 peer reviewed technical papers.

Xin Huang MD Ph.D.
Managing Partner, Cowin Venture

Dr. Xin Huang received his MD from Peking Union Medical College and PhD in Pharmacology and Molecular Sciences from School of Medicine, Johns Hopkins University. He then worked at Boston Consulting Group before he started his VC career in Omaha Capital. In 2012 he joined Cowin Venture and led the firm’s business in Healthcare sector. He has invested about 40 early stage healthcare start-ups in both China and the US during the past several years.

Ming Yan Ph.D.
Cytek Biosciences, C.T.O.

Dr. Yan is a co-founder of Cytek Biosciences, Inc. with over 20 years of R&D experience in leadership and innovation. Prior to Cytek®, Dr. Yan held research and development positions at AT&T Bell Laboratories, Lawrence Livermore National Labs and BD Biosciences. He is one of the thought-leaders in flow cytometry instrumentation and standardization. Dr. Yan has published several research papers relating to laser spectroscopy and cell analysis in top peer-reviewed journals. He has over a dozen patents and patent pending applications for his innovations.

Jack Ball
Solulink Inc., C.E.O.

Jack Ball is CEO and a board member at Solulink Inc. He is President of Tyball Associates, LLC. In addition, he serves on the board of directors of Aquaro Histology, Carterra, Celsee Diagnostics, Cytek Biosciences Inc., NanoCellect Inc. and Swift Bioscience. Most recently he was CCO at Accuri Cytometers, which was sold to Becton Dickinson in March 2011. Prior to Accuri Cytometers, he was CEO of Amnis Corporation, and has also served as CCO for Molecular Probes, Inc. Prior to that he was with Orchid Biosciences as Sr. VP and General Manager and with Amersham Pharmacia Biotech Inc., where he rose to President for North Amercia.

Feng Deng
Northern Light Venture Capital

Mr. Feng Deng founded Northern Light Venture Capital (NLVC) in 2005. He currently manages over US$ 4.5 billion. He has led and backed nearly 200 companies, focusing on 4 main sectors: TMT (technology, media and telecom), clean technology, healthcare and consumer. Prior to NLVC, Feng was a co-founder of NetScreen Technologies, which went public on NASDAQ and was later acquired by Juniper Networks in 2004 for US$ 4.2 billion. He has extensive technical and managerial experiences in computer, communication and data networking industries. Feng holds BS and MS degrees in electrical engineering from Tsinghua University, a MS degree in computer engineering from the University of Southern California, and a MBA degree from the Wharton School, University of Pennsylvania. He also holds numerous patents of invention in computer system architecture and IC design.

Dr. Yu Fang
3E-Bioventures Capital
Dr. Francine Fang joined 3E Bioventures as partner in May 2015. Prior to 3E Bioventures, Francine worked at Fidelity Growth Partners Asia (FGPA) as venture partner from 2014-2015. She led the investment transactions of Eyebright and Cytoville (Cytek). From 1998 to 2007, Francine worked at Clontech and BD Biosciences as a group leader in R&D for near 10 years in US. She led the assay development for high content screening in BioImaging group at BD Biosciences in San Jose. Before BD acquisition she led the cell biology group at Clontech for the commercialization of multi-color fluorescent proteins and signal transduction product. From 1996 to 1997, Francine worked as a postdoctor in Physiology at University of Medicine and Dentistry of New Jersey. She got Postdoctoral Fellowship from American Heart Association. Francine has Ph.D. degree in Physiology and Neuroscience at University of Medicine and Dentistry of New Jersey and M.D. degree in Medicine at Capital Institute of Medicine in Beijing China.
Dr. Allen Poirson
twoXAR

Dr. Poirson is an experienced life science executive and entrepreneur. Currently the Senior Vice President of Biopharmaceutical Business Development at twoXAR, he previously served as CEO and Chair of Sony Biotechnology. Dr. Poirson's domain expertise includes analytic instruments, computational biotechnology, medical devices, in vitro diagnostics, chemistry, and software. Allen has formal scientific training in neuroscience and has held research positions at Howard Hughes Medical Institute and NASA. Dr. Poirson obtained his PhD from Stanford.

Zheng Yuan
Shanghai Kinetic Co., Ltd.

Mr. Yuan Zheng Director and CEO. Worked in Chinese Academy of Preventive Medicine; Founder and General Manager of Former Shanghai Moore Biotech Co., Ltd.; Founder of KMC in 2005.

Scientific Advisory Board

Diether J. Recktenwald Ph.D.
Principal at Desatoya LLC
Bob Hoffman
Consultant in Flow Cytometry and Biophotonics
Holden Maecker Ph.D.
Professor of Microbiology and Immunology at Stanford University
Holden Maecker Ph.D.
Professor of Microbiology and Immunology at Stanford University
Dr. rer. nat. Andreas Radbruch
Professor at Deutsches Rheuma-Forschungszentrum – Berlin, Germany
Dr. Bill Telford
Associate Scientist and director of the flow cytometry core laboratory in the NCI Experimental Transplantation and Immunology Branch.

Partners

De Novo Software is a leading provider of flow and image cytometry analysis. Its primary product, FCS Express, is used by over 3,000 laboratories worldwide for research purposes, and dozens of clinical laboratories for high-throughput clinical analysis. As the first third-party flow analysis software listed with the FDA for in-vitro diagnostic use, and with full 21 CFR Part 11 compliance features, FCS Express is the analysis tool of choice for the clinical laboratory. In addition, De Novo Software has extensive experience creating custom data analysis solutions and integrating with large scale LIS and HIS systems. For more information, please visit www.denovosoftware.com.
The Astrolabe Cytometry Platform is a fast, reliable tool for the analysis of Cytek Aurora and Northern Lights data. Our customer-focused team provides the expertise of a computational biologist, and our platform provides efficient, reproducible results in 1-2 hours. Pinpoint biological insights with our intuitive interface and access paper-ready data visualizations with a mouseclick. Astrolabe uses cloud-based computing and peer-reviewed, published, state-of-the-art algorithms to unlock insights from your data. Learn more at astrolabediagnostics.com.
Verity Software House is committed to offering the finest analytical software for the international cytometry community. Established in 1982, we provide unequaled support for our clients and are continually developing new, accurate, automated analytical approaches. We extensively test our software before release to ensure reliable, reproducible results. GemStone™ is the perfect automated solution for your Aurora and Northern Lights data analysis. Get started with example templates for 16- and 33-color Cytek panels. Customize and create new templates for any number of measurements with user-friendly wizards. Analysis takes only minutes for per file, including report generation, Cen-se’ plots, and database output. For more information, please visit www.vsh.com.
OMIQ is a modern cloud platform for cytometry data analysis, built to maximize discovery power while minimizing time to result. OMIQ is designed around the principle of reproducible analytics and bridging the world of automated machine learning with that of classical manual analysis. The result is a single software in which a researcher can complete their entire workflow, going from raw data to statistical significance, using their own expertise and familiar tools seamlessly blended with dozens of cutting-edge computational methods and visualizations to unlock deeper insights from data. OMIQ uses sophisticated technical security, accepts SSO integration, and also supports custom scripts and IS integrations for enterprise customers. To learn more, visit www.omiq.ai.

Locations

United States - West Coast
46107 Landing Parkway
Fremont, CA 94538-6407
1-877-922-9835
United States - East Coast
4520 East West Highway
Suite 615
Bethesda, MD 20814
1-804-234-8110
Europe
Amstelveenseweg 648
1081 JJ, Amsterdam
The Netherlands
Phone: +31 (0) 20 765 3440
Fax: +31 (0) 20 765 3448
Japan
"EDGE" Building
2-9-1 Ikenohata Taito-ku
Tokyo 110-0008 Japan
China
560 Shengxia Road, Suite 603
Zhangjiang High-Tech Park
Shanghai Pilot Free Trade Zone, 201203
Phone: 86-21-60897568
Fax: 86-21-60897570